Silverback Therapeutics, Inc. (NASDAQ:SBTX – Get Free Report)’s share price rose 2% on Wednesday . The stock traded as high as $13.22 and last traded at $13.15. Approximately 1,794,287 shares were traded during trading, an increase of 431% from the average daily volume of 337,931 shares. The stock had previously closed at $12.89.
Silverback Therapeutics Stock Performance
The stock has a market cap of $455.41 million, a P/E ratio of -5.22 and a beta of 0.60. The business’s 50-day moving average price is $12.19 and its 200-day moving average price is $12.97.
About Silverback Therapeutics
Silverback Therapeutics, Inc, a biopharmaceutical company, develops tissue-targeted therapeutics for the treatment of chronic viral infections, cancer, and other serious diseases. The company offers SBT8230 to treat chronic hepatitis B virus infection by eliciting an anti-viral immune response by targeting TLR8 activation to the liver.
Featured Articles
- Five stocks we like better than Silverback Therapeutics
- EV Stocks and How to Profit from Them
- Why Dollar Tree’s Family Dollar Sale Could Spark a Comeback
- Retail Stocks Investing, Explained
- JPMorgan: The ‘NVIDIA of Banking’ Poised for More Gains?
- Ride Out The Recession With These Dividend Kings
- Buy the Chewy Stock Reversal? Here’s Why Now Is the Time
Receive News & Ratings for Silverback Therapeutics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Silverback Therapeutics and related companies with MarketBeat.com's FREE daily email newsletter.
